US EditionFDA approves first medication for obstructive sleep apnea, which also promotes weight loss
- Fda has approved the first medication for obstructive sleep apnea.
- The new medication also promotes weight loss.
- This approval is a significant advancement in treating obstructive sleep apnea.
- Healthcare professionals are optimistic about the potential impact of this medication.
27 Articles
27 Articles
FDA Approves Weight Loss Medication Zepbound to Treat Sleep Apnea
The FDA suggests that prescribed users also reduce their calorie intake and increase their exerciseShelby Knowles/Bloomberg via Getty Zepbound injection penThe weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of modera…
fox40jackson.com
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
close Video Sleep expert says this activity could help you get better rest at night Dr. Wendy Troxel, a sleep therapist in Utah, discusses a study that found small bouts of light exercise in the evening can help promote more restful sleep. The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound (tirze…
Science Alert
Shining ScienceThe FDA Just Approved The First US Drug Treatment For Sleep Apnea
US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans. "This is a major step forward for patients with obstructive sleep apnea," US Food and Drugs Administration official Sally Seymour said in a statement announcing approval of Zepbound to treat moderate to severe sleep apnea in obese patients.Zepbound, from drugmaker El…
Studies have shown that Zepbound helps significantly reduce episodes of shallow breathing. The FDA suggests that users combine Zepbound with a reduced-calorie diet and exercise. The drug is said to benefit both patients who use CPAP machines and those who don’t. The weight-loss drug Zepbound, known generically as tirzepatide, is now an approved drug for treating obstructive sleep apnea, according to People. The federal agency has approved the we…
Coverage Details
Bias Distribution
- 38% of the sources are Center, 37% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
